NIAID Banner Logo Image

Mycobacterium Citations List: June, 2019

Literature Citations

1. The Inhibitory Effect of Nisin on Mycobacterium avium ssp. Paratuberculosis and Its Effect on Mycobacterial Cell Wall. Ali, Z.I., A.M. Saudi, R. Albrecht, and A.M. Talaat. Journal of Dairy Science, 2019. 102(6): p. 4935-4944. PMID[30981481].
[PubMed]. TB_06_2019.

2. Design, Synthesis and in Silico Study of Pyridine Based 1,3,4-Oxadiazole Embedded Hydrazinecarbothioamide Derivatives as Potent Anti-tubercular Agent. Ambhore, A.N., S.S. Kamble, S.N. Kadam, R.D. Kamble, M.J. Hebade, S.V. Hese, M.V. Gaikwad, R.J. Meshram, R.N. Gacche, and B.S. Dawane. Computational Biology and Chemistry, 2019. 80: p. 54-65. PMID[30901601].
[PubMed]. TB_06_2019.

3. Fractions and Isolated Compounds from Oxyanthus speciosus subsp. Stenocarpus (Rubiaceae) Have Promising Antimycobacterial and Intracellular Activity. Aro, A.O., J.P. Dzoyem, M.D. Awouafack, M.A. Selepe, J.N. Eloff, and L.J. McGaw. BMC Complementary and Alternative Medicine, 2019. 19(108): 11pp. PMID[31117999]. PMCID[PMC6532187].
[PubMed]. TB_06_2019.

4. Novel MenA Inhibitors Are Bactericidal against Mycobacterium tuberculosis and Synergize with Electron Transport Chain Inhibitors. Berube, B.J., D. Russell, L. Castro, S.R. Choi, P. Narayanasamy, and T. Parish. Antimicrobial Agents and Chemotherapy, 2019. 63(6): e0217270. PMID[30962346]. PMCID[PMC6535543].
[PubMed]. TB_06_2019.

5. Design, Synthesis, Antimicrobial Evaluation, and Molecular Modeling Studies of Novel Indolinedione-Coumarin Molecular Hybrids. Bhagat, K., J. Bhagat, M.K. Gupta, J.V. Singh, H.K. Gulati, A. Singh, K. Kaur, G. Kaur, S. Sharma, A. Rana, H. Singh, S. Sharma, and P.M.S. Bedi. ACS Omega, 2019. 4(5): p. 8720-8730. ISI[000470094000093].
[WOS]. TB_06_2019.

6. 1,4-Benzoquinone Antimicrobial Agents against Staphylococcus aureus and Mycobacterium tuberculosis Derived from Scorpion Venom. Carcamo-Noriega, E.N., S. Sathyamoorthi, S. Banerjee, E. Gnanamani, M. Mendoza-Trujillo, D. Mata-Espinosa, R. Hernandez-Pando, J.I. Veytia-Bucheli, L.D. Possani, and R.N. Zare. Proceedings of the National Academy of Sciences of the United States of America, 2019. 116(26): p. 12642-12647. PMID[31182590].
[PubMed]. TB_06_2019.

7. Eugenol and Derivatives Activity against Mycobacterium tuberculosis, Nontuberculous Mycobacteria and Other Bacteria. de Almeida, A.L., K.R. Caleffi-Ferracioli, L.S.R.B. de, V.P. Baldin, D.C. Montaholi, L.F. Spricigo, S.S. Nakamura-Vasconcelos, L.A. Hegeto, E.G. Sampiron, G.F. Costacurta, S.Y.D.A. Dos, F.G. G, V.L. Siqueira, and R.F. Cardoso. Future Microbiology, 2019. 14: p. 331-344. PMID[30757916].
[PubMed]. TB_06_2019.

8. 4H-1,3-Benzothiazin-4-one a Promising Class against MDR/XDR-Tb. de Souza, M.V.N. and T.C.M. Nogueira. Current Topics in Medicinal Chemistry, 2019. 19(8): p. 567-578. PMID[30834835].
[PubMed]. TB_06_2019.

9. Production of New Antibacterial 4-Hydroxy-alpha-pyrones by a Marine Fungus Aspergillus niger Cultivated in Solid Medium. Ding, L., L. Ren, S. Li, J. Song, Z. Han, S. He, and S. Xu. Marine Drugs, 2019. 17(6): e344. PMID[31185700].
[PubMed]. TB_06_2019.

10. Tryptanthrin Analogues as Inhibitors of Enoyl-acyl Carrier Protein Reductase: Activity against Mycobacterium tuberculosis, Toxicity, Modeling of Enzyme Binding. Duca, G., S. Pogrebnoi, V. Boldescu, F. Aksakal, A. Uncu, V. Valica, L. Uncu, S. Negres, F. Nicolescu, and F. Macaev. Current Topics in Medicinal Chemistry, 2019. 19(8): p. 609-619. PMID[30834838].
[PubMed]. TB_06_2019.

11 Benzofuran-Isatin Hybrids Tethered via Different Length Alkyl Linkers and Their in Vitro Anti-mycobacterial Activities. Gao, F., Z. Chen, L. Ma, L. Qiu, J. Lin, and G. Lu. Bioorganic and Medicinal Chemistry, 2019. 27(12): p. 2652-2656. PMID[30992202].
[PubMed]. TB_06_2019.

12. Synthesis and Evaluation of New Quinazolin-4(3H)-one Derivatives as Potent Antibacterial Agents against Multidrug Resistant Staphylococcus aureus and Mycobacterium tuberculosis. Gatadi, S., J. Gour, M. Shukla, G. Kaul, A. Dasgupta, Y.V. Madhavi, S. Chopra, and S. Nanduri. European Journal of Medicinal Chemistry, 2019. 175: p. 287-308. PMID[31096152].
[PubMed]. TB_06_2019.

13. Activities of Biapenem against Mycobacterium tuberculosis in Macrophages and Mice. Guo, Z.Y., W.J. Zhao, M.Q. Zheng, S. Liu, C.X. Yan, P. Li, and S.F. Xu. Biomedical and Environmental Sciences, 2019. 32(4): p. 235-241. PMID[31217059].
[PubMed]. TB_06_2019.

14. Targeting Extracellular Glycans: Tuning Multimeric Boronic acids for Pathogen-selective Killing of Mycobacterium tuberculosis. Guy, C.S., M.I. Gibson, and E. Fullam. Chemical Science, 2019. 10(23): p. 5935-5942. ISI[000471133800007].
[WOS]. TB_06_2019.

15. Discovery of Nosiheptide, Griseoviridin, and Etamycin as Potent Anti-mycobacterial Agents against Mycobacterium avium Complex. Hosoda, K., N. Koyama, A. Kanamoto, and H. Tomoda. Molecules, 2019. 24(8): e1495. PMID[30995807]. PMCID[PMC6514863].
[PubMed]. TB_06_2019.

16. Cordycepin Kills Mycobacterium tuberculosis through Hijacking the Bacterial Adenosine Kinase. Huang, F., W. Li, H. Xu, H. Qin, and Z.G. He. Plos One, 2019. 14(6): e0218449. PMID[31199855]. PMCID[PMC6568415].
[PubMed]. TB_06_2019.

17. The Combination Rifampin-Nitazoxanide, but Not Rifampin-Isoniazid-Pyrazinamide-Ethambutol, Kills Dormant Mycobacterium tuberculosis in Hypoxia at Neutral pH. Iacobino, A., F. Giannoni, M. Pardini, G. Piccaro, and L. Fattorini. Antimicrobial Agents and Chemotherapy, 2019. 63(7): e00273. PMID[31010861].
[PubMed]. TB_06_2019.

18. In Vitro Activity of DNF-3 against Drug-Resistant Mycobacterium tuberculosis. Islam, M.I., C.M. Han, H. Seo, S. Kim, H.A. Mahmud, K.W. Nam, B.E. Lee, V.S. Sadu, K.I. Lee, and H.Y. Song. International Journal of Antimicrobial Agents, 2019. 54(1): p. 69-74. PMID[30807817].
[PubMed]. TB_06_2019.

19. In Vitro, in Silico and ex Vivo Studies of Dihydroartemisinin Derivatives as Antitubercular Agents. Kalani, K., S. Alam, V. Chaturvedi, S. Singh, F. Khan, and S.K. Srivastava. Current Topics in Medicinal Chemistry, 2019. 19(8): p. 633-644. PMID[30834834].
[PubMed]. TB_06_2019.

20. Efficient Synthesis, Antitubercular and Antimicrobial Evaluation of 1,4-Disubstituted 1,2,3-triazoles with Amide Functionality. Kaushik, C.P., A. Pahwa, D. Singh, K. Kumar, and R. Luxmi. Monatshefte fur Chemie, 2019. 150(6): p. 1127-1136. ISI[000469766500018].
[WOS]. TB_06_2019.

21. Synthesis and Study of New Quinolineaminoethanols as Anti-bacterial Drugs. Laumaille, P., A. Dassonville-Klimpt, F. Peltier, C. Mullie, C. Andrejak, S. Da-Nascimento, S. Castelain, and P. Sonnet. Pharmaceuticals, 2019. 12(2): e91. PMID[31216783].
[PubMed]. TB_06_2019.

22. Direct Inhibition of MmpL3 by Novel Antitubercular Compounds. Li, W., C.M. Stevens, A.N. Pandya, Z. Darzynkiewicz, P. Bhattarai, W. Tong, M. Gonzalez-Juarrero, E.J. North, H.I. Zgurskaya, and M. Jackson. ACS Infectious Diseases, 2019. 5(6): p. 1001-1012. PMID[30882198]. PMCID[PMC6580365].
[PubMed]. TB_06_2019.

23. Advancing the Therapeutic Potential of Indoleamides for Tuberculosis. Lun, S., R. Tasneen, T. Chaira, J. Stec, O.K. Onajole, T.J. Yang, C.B. Cooper, K. Mdluli, P.J. Converse, E.L. Nuermberger, V.S. Raj, A. Kozikowski, and W.R. Bishai. Antimicrobial Agents and Chemotherapy, 2019. 63(7): e00343. PMID[31010860].
[PubMed]. TB_06_2019.

24. New Ternary Iron(III) Aminobisphenolate Hydroxyquinoline Complexes as Potential Therapeutic Agents. Matos, C.P., Y. Yildizhan, Z. Adiguzel, F.R. Pavan, D.L. Campos, J.C. Pessoa, L.P. Ferreira, A.I. Tomaz, I. Correia, and C. Acilan. Dalton Transactions, 2019. 48(24): p. 8702-8716. PMID[31123737].
[PubMed]. TB_06_2019.

25. Preclinical Pharmacokinetic and Pharmacodynamic Data to Support Cefoxitin Nebulization for the Treatment of Mycobacterium abscessus. Mehta, S., V. Aranzana-Climent, B. Rammaert, N. Gregoire, S. Marchand, W. Couet, and J.M. Buyck. Antimicrobial Agents and Chemotherapy, 2019. 63(7): e02651. PMID[31061149].
[PubMed]. TB_06_2019.

26. Structure-based Design, Synthesis and Biological Evaluation of a Newer Series of Pyrazolo[1,5-a]pyrimidine Analogues as Potential Anti-tubercular Agents. Modi, P., S. Patel, and M. Chhabria. Bioorganic Chemistry, 2019. 87: p. 240-251. PMID[30908967].
[PubMed]. TB_06_2019.

27. Identification of Anti-mycobacterial Biofilm Agents Based on the 2-Aminoimidazole Scaffold. Nguyen, T.V., B.M. Minrovic, R.J. Melander, and C. Melander. ChemMedChem, 2019. 14(9): p. 927-937. PMID[30834698].
[PubMed]. TB_06_2019.

28. Novel Antimycobacterial Compounds Suppress NAD Biogenesis by Targeting a Unique Pocket of NaMN Adenylyltransferase. Osterman, A.L., I. Rodionova, X.Q. Li, E. Sergienko, C.T. Ma, A. Catanzaro, M.E. Pettigrove, R.W. Reed, R. Gupta, K.H. Rohde, K.V. Korotkov, and L. Sorci. ACS Chemical Biology, 2019. 14(5): p. 949-958. PMID[30969758].
[PubMed]. TB_06_2019.

29. Ultrasonication-ionic Liquid Synergy for the Synthesis of New Potent Anti-tuberculosis 1,2,4-Triazol-1-yl-pyrazole Based Spirooxindolopyrrolizidines. Pogaku, V., V.S. Krishna, D. Sriram, K. Rangan, and S. Basavoju. Bioorganic & Medicinal Chemistry Letters, 2019. 29(13): p. 1682-1687. PMID[31047752].
[PubMed]. TB_06_2019.

30. Bacterial Adhesion and Biofilm Formation in the Presence of Chitosan and Its Derivatives. Polyudova, T.V., B.T. Shagdarova, V.P. Korobov, and V.P. Varlamov. Microbiology, 2019. 88(2): p. 125-131. ISI[000468603300001].
[WOS]. TB_06_2019.

31. Bioactive Homogentisic acid Derivatives from Fruits and Flowers of Miliusa velutina. Promgool, T., K. Kanokmedhakul, S. Tontapha, V. Amornkitbamrung, S. Tongpim, W. Jamjan, and S. Kanokmedhakul. Fitoterapia, 2019. 134: p. 65-72. PMID[30768952].
[PubMed]. TB_06_2019.

32. Trixis angustifolia Hexanic Extract Displays Synergistic Antibacterial Activity against M. tuberculosis. Sanchez-Chavez, A.C., A. Salazar-Gomez, L.G. Zepeda-Vallejo, M.L. Hernandez de Jesus, M. Quintos-Escalante, M.E. Vargas-Diaz, and J. Luna-Herrera. Natural Product Research, 2019. 33(10): p. 1477-1481. PMID[29277116].
[PubMed]. TB_06_2019.

33. Synthesis and Biological Activity of 3,4,-tri-O-Acetyl-N-acetylglucosamine and Tetraacetylglucopyranose Conjugated with Alkyl Phosphates. Sharipova, R.R., B.F. Garifullin, A.S. Sapunova, A.D. Voloshina, M.A. Kravchenko, and V.E. Kataev. Russian Journal of Bioorganic Chemistry, 2019. 45(2): p. 155-164. ISI[000470325600011].
[WOS]. TB_06_2019.

34. Synthesis and Structure-Activity Relationship of 1-(5-Isoquinolinesulfonyl)piperazine Analogues as Inhibitors of Mycobacterium tuberculosis IMPDH. Singh, V., A. Pacitto, S. Donini, D.M. Ferraris, S. Boros, E. Illyes, B. Szokol, M. Rizzi, T.L. Blundell, D.B. Ascher, J. Pato, and V. Mizrahi. European Journal of Medicinal Chemistry, 2019. 174: p. 309-329. PMID[31055147].
[PubMed]. TB_06_2019.

35. 3D QSAR-based Design and Liquid Phase Combinatorial Synthesis of 1,2-disubstituted Benzimidazole-5-carboxylic acid and 3-Substituted-5H-benzimidazo[1,2-D][1,4]benzodiazepin-6(7H)-one Derivatives as Anti-mycobacterial Agents. Sitwala, N.D., V.K. Vyas, P. Gedia, K. Patel, R. Bouzeyen, S. Kidwai, R. Singh, and M.D. Ghate. MedChemComm, 2019. 10(5): p. 817-827. ISI[000468790800018].
[WOS]. TB_06_2019.

36. Synthesis, Antitubercular Activity, and Molecular Docking Studies of Novel 2-(4-Chlorobenzylamino)-4-(cyclohexylmethylamino)-pyrimidine-5-carboxamides. Srinu, B., R. Parameshwar, G.K. Charan, E. Srinivas, C.P.K. Rao, J. Chandra, and S.N. Varma. Russian Journal of General Chemistry, 2019. 89(4): p. 836-843. ISI[000469246900032].
[WOS]. TB_06_2019.

37. Screening of Anti-mycobacterial Phytochemical Compounds for Potential Inhibitors against Mycobacterium tuberculosis Isocitrate Lyase. Tiwari, A., A. Kumar, G. Srivastava, and A. Sharma. Current Topics in Medicinal Chemistry, 2019. 19(8): p. 600-608. PMID[30836915].
[PubMed]. TB_06_2019.

38. Antitubercular Activity of the Fungus Gliocladium sp. MR41 Strain. Uc-Cachon, A.H., M. Gamboa-Angulo, R. Borges-Argaez, M. Reyes-Estebanez, S. Said-Fernandez, and G.M. Molina-Salinas. Iranian Journal of Pharmaceutical Research, 2019. 18(2): p. 860-866. ISI[000468959200028].
[WOS]. TB_06_2019.

39. Tetrahydropyridine Derivative as Efflux Inhibitor in Mycobacterium abscessus. Vianna, J.S., I.B. Ramis, D. Bierhals, A. von Groll, D.F. Ramos, N. Zanatta, M.C. Lourenco, M. Viveiros, and P.E. Almeida da Silva. Journal of Global Antimicrobial Resistance, 2019. 17: p. 296-299. PMID[30630106].
[PubMed]. TB_06_2019.

40. A Small Mycobacteriophage-derived Peptide and Its Improved Isomer Restrict Mycobacterial Infection via Dual Mycobactericidal-Immunoregulatory Activities. Yang, Y., Z. Liu, X. He, J. Yang, J. Wu, H. Yang, M. Li, Q. Qian, R. Lai, W. Xu, and L. Wei. Journal of Biological Chemistry, 2019. 294(19): p. 7615-7631. PMID[30894414]. PMCID[PMC6514635].
[PubMed]. TB_06_2019.

Patent Citations

41. Chemical Compositions with Antimicrobial Functionality for Targeting Pathogens. Fevre, M.B., J.L. Hedrick, N.H. Park, V.A. Piunova, P.K.J. Tan, C. Yang, and Y.Y. Yang. Patent. 2019. 2017-15839410 20190177479: 26pp.
[Patent]. TB_06_2019.

If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: May 2019